LIVER DISEASES

This study tested a new patch called GATT-Patch to see how well it stops bleeding during minimally invasive liver and gallbladder surgery. It involved 53 adults having keyhole surgery. The patch was compared to a standard product to see if it could control bleeding within 7 minut…

This study tested a new surgical patch called GATT-Patch against an existing patch called TachoSil. The goal was to see which patch works better to stop bleeding during planned open liver surgery. Researchers enrolled 132 patients across multiple hospitals to compare how quickly …

This study looked at whether mindfulness exercises can lower stress and improve communication between patients with liver disease and their doctors. 56 adults took part. Researchers measured stress, anxiety, and how well patients felt they could share in decisions about their car…

This study used leftover liver tissue from 36 adults who had surgery to create lab models that mimic early infection. The goal was to understand how bacteria and viruses first take hold in the liver and to test potential treatments. The research focused on liver immune cells call…

This study checked if a special MRI scan called LiverMultiScan gives the same results when repeated on the same machine or on different machines. 61 adults with various liver diseases were scanned multiple times. The goal was to see if the scan reliably measures liver fat, iron, …

This study looked at 52 adults who had a living-donor liver transplant to see if using a microscope or surgical loupes (magnifying glasses) leads to fewer bile duct problems after surgery. The goal was to find out which tool helps reduce complications like leaks or narrowing of t…

This study tested a program called GRACE that helps primary care patients understand their genetic risk for conditions like heart disease and cancer. Researchers worked with 245 patients, their doctors, and family members to see if the program could be used in different clinics, …

This study tested whether a breath analysis test could help diagnose or predict the course of liver diseases, liver cancer, and COVID-19. Researchers collected breath samples from 46 participants to detect unique chemical patterns. The goal was to develop a non-invasive diagnosti…

This study looked at how the body handles a single dose of the experimental drug etavopivat in people with different levels of liver disease. 48 adults with mild, moderate, or severe liver problems, plus some with healthy livers, took one pill. Researchers measured drug levels in…

This study tested whether an electronic alert in medical records could help doctors refer patients with fatty liver disease (NASH) to liver specialists. It involved 30 doctors from internal medicine, family medicine, and endocrinology. The goal was to see if the alert increased a…

This study looked at how moderate liver problems affect the way the body handles a new cancer medicine called sevabertinib. About 20 people (10 with liver impairment and 10 healthy) took a single dose and had their blood levels measured. The goal is to help doctors decide the rig…